Hodgkin Lymphoma
📧 Sign up to get email alerts when something new happens for Hodgkin Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-10-26Clinical Trial Update: Brentuximab for Newly Diagnosed Hodgkin Disease [Phase 2]
Phase 2 clinical trial update evaluating brentuximab for newly diagnosed Hodgkin lymphoma has completed.
-
CLINICAL_TRIALS trial_result · 2023-10-13Clinical Trial Update: A Study of Retreatment With Brentuximab Vedotin in Subjects With Classic Hodgkin Lymphoma or CD30-expressing Peripheral T Cell Lymphoma [Phase 2]
A Phase 2 trial evaluating retreatment with brentuximab vedotin in classic Hodgkin lymphoma and CD30-expressing peripheral T-cell lymphoma h…
-
CLINICAL_TRIALS trial_result · 2023-09-28Clinical Trial Update: Combination Chemotherapy Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or High-Risk Primary Refractory Hodgkin Lymphoma [Phase 2]
Phase 2 trial evaluating combination chemotherapy followed by donor stem cell transplant in relapsed or high-risk primary refractory Hodgkin…
-
CLINICAL_TRIALS trial_result · 2023-09-28Clinical Trial Update: Methods of T Cell Depletion Trial (MoTD) [Phase 2]
Phase 2 trial update for methods of T cell depletion in various hematologic malignancies is ongoing.
-
CLINICAL_TRIALS trial_result · 2023-09-21Clinical Trial Update: Combination of Nivolumab and DHAP in Patients With Relapsed or Refractory Classical Hodgkin Lymphoma (Nivo-DHAP) [Phase 2]
A Phase 2 trial assessing the combination of nivolumab with DHAP in relapsed or refractory classical Hodgkin lymphoma has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-08-21Clinical Trial Update: A Phase II Study to Determine Pembrolizumab as Frontline Treatment of Patients With Hodgkin Lymphoma [Phase 2]
Phase II study investigating frontline pembrolizumab in Hodgkin lymphoma is in progress with status currently unknown.
-
CLINICAL_TRIALS trial_result · 2023-07-20Clinical Trial Update: Gene Therapy in Treating Patients With Human Immunodeficiency Virus-Related Lymphoma Receiving Stem Cell Transplant [Phase 1, Phase 2]
This update reports results from a Phase 1/2 clinical trial of a gene therapy for HIV-related lymphomas in patients undergoing stem cell tra…
-
CLINICAL_TRIALS trial_result · 2023-07-13Clinical Trial Update: Once Daily Targeted Intravenous (IV) Busulfex as Part of Reduced-toxicity Conditioning for Patients With Refractory Lymphomas Undergoing Allogeneic Transplantation [Phase 2]
Phase 2 trial update on once-daily targeted IV busulfan as part of reduced-toxicity conditioning for patients with refractory lymphomas unde…
-
CLINICAL_TRIALS trial_result · 2023-07-12Clinical Trial Update: Vaccine Therapy in Reducing the Frequency of Cytomegalovirus Events in Patients With Hematologic Malignancies Undergoing Donor Stem Cell Transplant [Phase 2]
Phase 2 trial evaluating a vaccine therapy to reduce cytomegalovirus events in patients with hematologic malignancies undergoing donor stem …
-
CLINICAL_TRIALS trial_result · 2023-07-10Clinical Trial Update: Ibrutinib and Brentuximab Vedotin in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma [Phase 2]
A Phase 2 trial evaluates the combination of ibrutinib and brentuximab vedotin in relapsed or refractory Hodgkin lymphoma. The study has com…
-
CLINICAL_TRIALS trial_result · 2023-06-29Clinical Trial Update: Allogeneic Transplantation Using Timed Sequential Busulfan and Fludarabine Conditioning [Phase 2]
Phase 2 trial update on allogeneic transplantation using timed sequential busulfan and fludarabine conditioning for various hematologic mali…
-
CLINICAL_TRIALS trial_result · 2023-06-28Clinical Trial Update: Lymphoma RadVax LYMPHOMA: A PHASE II TRIAL OF NIVOLUMAB + LOW DOSE RADIOTHERAPY FOR INCOMPLETE RESPONDERS [Phase 2]
Phase II trial evaluating nivolumab with low-dose radiotherapy for incomplete responders with Hodgkin lymphoma is terminated; results posted…
-
CLINICAL_TRIALS trial_result · 2023-06-09Clinical Trial Update: High Dose Cyclophosphamide, Tacrolimus, and Mycophenolate Mofetil in Preventing Graft Versus Host Disease in Patients With Hematological Malignancies Undergoing Myeloablative or Reduced Intensity Donor Stem Cell Transplant [Phase 2]
Phase 2 clinical trial evaluating high-dose cyclophosphamide, tacrolimus, and mycophenolate mofetil to prevent graft-versus-host disease in …
-
CLINICAL_TRIALS trial_result · 2023-06-09Clinical Trial Update: Nivolumab Maintenance Therapy After Autologous Stem Cell Transplant in Hodgkin Lymphoma Pts at Relapse/Progression Risk [Phase 2]
Phase 2 trial evaluating nivolumab as maintenance therapy after autologous stem cell transplant in Hodgkin lymphoma patients at relapse/prog…
-
CLINICAL_TRIALS trial_result · 2023-06-02Clinical Trial Update: Pembrolizumab and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma [Phase 2]
Phase 2 trial evaluating pembrolizumab in combination with chemotherapy for relapsed or refractory Hodgkin lymphoma; status and results are …
-
CLINICAL_TRIALS trial_result · 2023-05-31Clinical Trial Update: Brentuximab Vedotin and Combination Chemotherapy in Treating Children and Young Adults With Stage IIB, Stage IIIB, IVA, or IVB Hodgkin Lymphoma [Phase 3]
Phase 3 trial evaluating brentuximab vedotin combined with chemotherapy in children and young adults with advanced Hodgkin lymphoma (stages …
-
CLINICAL_TRIALS trial_result · 2023-05-31Clinical Trial Update: Brentuximab Vedotin and Combination Chemotherapy in Treating Children and Young Adults With Stage IIB, Stage IIIB, IVA, or IVB Hodgkin Lymphoma [Phase 3]
Phase 3 trial evaluating brentuximab vedotin in combination chemotherapy for pediatric and young adult Hodgkin lymphoma across advanced-stag…
-
CLINICAL_TRIALS trial_result · 2023-05-03Clinical Trial Update: Umbralisib and Pembrolizumab in Treating Patients With Relapsed or Refractory Classical Hodgkin Lymphoma [Phase 2]
Phase 2 trial investigating umbralisib and pembrolizumab in relapsed or refractory classical Hodgkin lymphoma was terminated with results po…
-
CLINICAL_TRIALS trial_result · 2023-04-27Clinical Trial Update: Tazemetostat in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With EZH2, SMARCB1, or SMARCA4 Gene Mutations (A Pediatric MATCH Treatment Trial) [Phase 2]
This Phase 2 pediatric MATCH trial update reports results for tazemetostat in patients with relapsed or refractory solid tumors, non-Hodgkin…
-
CLINICAL_TRIALS trial_result · 2023-04-27Clinical Trial Update: Reduced Intensity Conditioning Transplant Using Haploidentical Donors [Phase 2]
Phase 2 clinical trial investigating reduced intensity conditioning transplant using haploidentical donors for various hematologic malignanc…
-
CLINICAL_TRIALS trial_result · 2023-04-18Clinical Trial Update: Enhancing Effect on Tumour Apoptosis With the Use of Pentoxifylline in Patients With Hodgkin Lymphoma [Phase 4]
Phase 4 clinical trial investigating pentoxifylline to enhance tumor cell death in Hodgkin lymphoma.
-
CLINICAL_TRIALS trial_result · 2023-04-12Clinical Trial Update: A Study of Safety and Efficacy of PET-adapted Treatment With Nivolumab at the Fixed Dose 40 mg, Ifosfamide, Carboplatin, Etoposide (NICE-40) in Patients With Relapsed/Refractory Hodgkin Lymphoma [Phase 1, Phase 2]
A phase 1/2 clinical trial evaluating safety and efficacy of a PET-adapted fixed-dose nivolumab regimen with ifosfamide, carboplatin, and et…
-
CLINICAL_TRIALS trial_result · 2023-04-05Clinical Trial Update: Phase 2 Study Evaluating Autologous CD30.CAR-T Cells in Patients With Relapsed/Refractory Hodgkin Lymphoma (CHARIOT) [Phase 2]
Phase 2 trial update for autologous CD30.CAR-T cells in relapsed/refractory Hodgkin lymphoma (CHARIOT) is ongoing (Phase 2, active not recru…
-
CLINICAL_TRIALS trial_result · 2023-01-23Clinical Trial Update: Adoptive Immunotherapy in Relapsed Hematological Malignancy: Early GVHD Prophylaxis [Phase 2]
Phase 2 trial of adoptive immunotherapy in relapsed hematological malignancies with early GVHD prophylaxis has completed enrollment and post…
-
CLINICAL_TRIALS trial_result · 2023-01-20Clinical Trial Update: Ibrutinib in Treating Patients With Refractory or Relapsed Lymphoma After Donor Stem Cell Transplant [Phase 2]
Phase 2 trial evaluating ibrutinib in patients with refractory or relapsed lymphoma after donor stem cell transplant completed; results post…